[Effect of spironolactone on the excretion of sodium and potassium in the saliva in secondary hyperaldosteronism].
D006333:Heart Failure / Q000378:metabolism; D006801:Humans; D006929:Hyperaldosteronism / Q000378:metabolism* / Q000628:therapy; D008103:Liver Cirrhosis / Q000378:metabolism; D011188:Potassium / Q000032:analysis*; D012463:Saliva / Q000032:analysis*; D012964:Sodium / Q000032:analysis*; D013148:Spironolactone / Q000494:pharmacology*
D013148:Spironolactone; D012964:Sodium; D011188:Potassium
Ucinek spirolaktonu na vylucováni natria a kalia slinamie pri sekundárnim hyperaldosteronismu.